Navigation Links
Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study
Date:12/16/2009

CHICAGO, Dec. 16 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today announced positive top-line results from a pivotal, non-human primate study of its novel, once-a-day, oral antibiotic Restanza(TM) (cethromycin) against an inhaled lethal dose of tularemia. A 14-day course of Restanza achieved a 100% survival rate at the doses tested. All of the ten animals in the study that received 16 mg/kg once-a-day of Restanza (approximate to a human dose of 300 mg) within 24 hours after exposure to a lethal dose of inhaled tularemia survived while only one of the ten animals that received placebo survived.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO)

"We believe that the impressive survival data in tularemia, combined with previously reported survival data in anthrax and plague, confirm the profile of Restanza as a potent, broad spectrum medical countermeasure for biodefense and underscore Restanza's impressive efficacy and safety against lethal pathogens which could represent significant threats to public health and safety," said Michael T. Flavin, Ph.D., chairman and chief executive officer of Advanced Life Sciences. "We believe that our company's biodefense strategy represents a promising commercial opportunity and we are excited about the scope and pace of our progress to date. One of Restanza's major differentiating advantages, and a key characteristic that has attracted US government interest, is its demonstrated breadth of activity against many lethal pathogens."

Tularemia is a bacterial disease commonly transmitted to humans through contact with infected rodents or rabbits or through insects that carry Francisella( )tularensis, the causative agent of tularemia, which is classified by the Cen
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Aug. 4, 2015 Young Innovations ("Young"), ... equipment, today announced the acquisition of the professional ... Inc. ("MPL PDCMD"). MPL PDCMD manufactures fluoride varnish, ... and restorative dental procedures. "This ... business in attractive, high-growth segments," said Dave ...
(Date:8/4/2015)... 2015  Sangamo BioSciences, Inc. (NASDAQ: SGMO ) ... Sangamo,s executive vice president, research and development, will provide ... ® development programs and an overview of the ... 11, 2015, at the 2015 Wedbush Pacgrow Healthcare Conference. ... York, NY . The presentation will ...
(Date:8/4/2015)... -- HeartWare International, Inc . (NASDAQ: HTWR ... support technologies that are revolutionizing the treatment of advanced ... Executive Officer, Doug Godshall , is scheduled to ... at 8:30 a.m. EDT on Thursday, August 13, 2015.  ... the InterContinental Boston. A live webcast of ...
Breaking Medicine Technology:Young Innovations Announces Acquisition of Medical Products Laboratories' Professional Dental Contract Manufacturing Division 2Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference 2HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2
... Alarmist Messages Reflect Group,s Anti-Meat Bias, Stand,in Sharp ... Sense, WASHINGTON, Oct. 31 The American ... Fund,s (WCRF),recommendations to limit red and processed meat ... bias and should be met with,skepticism because they ...
... Oct. 30 Although Spanish-speaking cancer,patients are rapidly ... Internet, there are very few Spanish-language Web sites,available ... presented,October 28, 2007, at the American Society for ... Angeles. Spanish-speaking cancer patients were also shown ...
Cached Medicine Technology:American Meat Institute Calls WCRF Panel Recommendations on Meat Consumption Extreme and Unfounded 2American Meat Institute Calls WCRF Panel Recommendations on Meat Consumption Extreme and Unfounded 3American Meat Institute Calls WCRF Panel Recommendations on Meat Consumption Extreme and Unfounded 4Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce 2
(Date:8/4/2015)... ... 2015 , ... Rhode Island Medical Imaging (RIMI) is pleased to announce the ... Wake Robin Road in Lincoln, RI. This satellite office will provide x-ray and ... out-patient x-ray hours in the state, which includes evenings and weekends. , “This ...
(Date:8/4/2015)... California (PRWEB) , ... August 04, 2015 , ... ... slides to Los Angeles commercial customers. Finding reliable hardware can be difficult ... liabilities. When putting an office together or designing a new facility, it ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... States, Richard Carmona, M.D., M.P.H., FACS, to its Board of Directors effective August ... save lives," Dr. Carmona said. "I strongly believe in the mission of the ...
(Date:8/4/2015)... ... 04, 2015 , ... Recent studies in the ... in binge drinking among certain populations and specific locations. Researchers, who ... examine trends and evidence to help facilitate health care treatment to meet current ...
(Date:8/4/2015)... ... August 04, 2015 , ... 24/7 Care At ... Angeles, Riverside, and San Bernardino, today announced that the U.S. Department of Veteran’s Affairs ... 24/7 Care At Home’s agency is well on the path to meeting the aspirational ...
Breaking Medicine News(10 mins):Health News:Rhode Island Medical Imaging Opens Satellite Imaging Center on Wake Robin Road in Lincoln 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3Health News:24/7 Care At Home Receives Two Stars from the VA 2Health News:24/7 Care At Home Receives Two Stars from the VA 3
... Practice DirectorWESTFIELD, Ind., Feb. 10 maxIT Healthcare ... new division to provide technical and functional professional ... Healthcare, a leading professional services company for healthcare ... a presence in the health insurance market to ...
... de foie gras is discussed by Michael Greger of The ... forthcoming issue of the International Journal of Food Safety, ... as amyloid fibrils associated with damage to brain cells in ... can be present in the meat of poultry and mammals. ...
... launch a new national research centre to further understanding ... Centre, which will be opened by Sir William Stewart, ... 12 in the country to be funded by the ... the Government,s health research strategy. The joint venture has ...
... CHARLOTTE, N.C., Feb. 10 USHIFU, a worldwide ... invasive high intensity focused,ultrasound technologies, is pleased to ... consulting position of Chief Medical Officer. Dr.,Schoenberg is ... Urologic,Oncology who has authored more than 100 peer-reviewed ...
... 10 Erdman, A Cogdell Spencer,Company is pleased ... has earned the U.S. Environmental Protection Agency,s (EPA,s),prestigious ... efficiency,and environmental protection. America,s commercial buildings and industrial,plants ... similar facilities for energy,efficiency may qualify for the ...
... NUVA ), a medical device company focused ... the spine, announced today that Kevin O,Boyle, Executive Vice ... at the ROTH 21st Annual OC Growth Stock Conference ... Tuesday, February 17, 2009, at 11:30 a.m. PT.A live ...
Cached Medicine News:Health News:maxIT Healthcare Launches Healthcare Payer Professional Services Unit 2Health News:Give the foie gras a miss 2Health News:Biomedical research center opens in Liverpool 2Health News:USHIFU Appoints Mark Schoenberg, M.D. Chief Medical Officer 2Health News:Erdman, A Cogdell Spencer Company Earns the ENERGY STAR(R) for Superior Energy 2Health News:Erdman, A Cogdell Spencer Company Earns the ENERGY STAR(R) for Superior Energy 3Health News:Erdman, A Cogdell Spencer Company Earns the ENERGY STAR(R) for Superior Energy 4Health News:NuVasive to Present at ROTH 21st Annual OC Growth Stock Conference 2Health News:NuVasive to Present at ROTH 21st Annual OC Growth Stock Conference 3
A simple solution to hand assisted laparoscopic surgery....
... The HandPort Systems non-adhesive ... during Hand-Assisted Laparoscopic Surgrery (HALS) ... touch, grasp, and palpate throughout. ... small as 6 cm, patients ...
... 200 series offers a range of ... The design delivers therapy to meet ... promote results in commercial and clinical ... differentiator in the SleepStyle 200 series ...
The SleepStyle 600 series with ThermoSmart delivers humidification with anti-rainout benefits. ThermoSmart technology offers a heated breathing tube that allows the constant delivery of optimal level...
Medicine Products: